Jeonjinbio Co. Ltd (110020) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩313.21 Million ≈ $212.26K USD) by net assets (₩17.72 Billion ≈ $12.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jeonjinbio Co. Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Jeonjinbio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Jeonjinbio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jeonjinbio Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jeonjinbio Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
S F Capital Bhd
KLSE:8745
|
-0.255x |
|
Metals Australia Ltd
AU:MLS
|
-0.014x |
|
ZincX Resources Corp
V:ZNX
|
-0.004x |
|
Pharmacielo Ltd
V:PCLO
|
0.236x |
|
Skin Elements Ltd
AU:SKN
|
-0.699x |
|
Kadestone Capital Corp
V:KDSX
|
-0.401x |
|
VOGO SA
PA:ALVGO
|
0.133x |
|
Rewardle Holdings Ltd
AU:RXH
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Jeonjinbio Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Jeonjinbio Co. Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩17.66 Billion ≈ $11.97 Million |
₩3.01 Billion ≈ $2.04 Million |
0.170x | +452.06% |
| 2023-12-31 | ₩6.22 Billion ≈ $4.21 Million |
₩-300.60 Million ≈ $-203.71K |
-0.048x | +87.61% |
| 2022-12-31 | ₩9.51 Billion ≈ $6.44 Million |
₩-3.71 Billion ≈ $-2.51 Million |
-0.390x | -76.65% |
| 2021-12-31 | ₩10.80 Billion ≈ $7.32 Million |
₩-2.38 Billion ≈ $-1.62 Million |
-0.221x | -7.88% |
| 2020-12-31 | ₩11.28 Billion ≈ $7.65 Million |
₩-2.31 Billion ≈ $-1.57 Million |
-0.205x | +54.32% |
| 2019-12-31 | ₩2.90 Billion ≈ $1.96 Million |
₩-1.30 Billion ≈ $-880.34K |
-0.448x | +18.90% |
| 2018-12-31 | ₩3.91 Billion ≈ $2.65 Million |
₩-2.16 Billion ≈ $-1.46 Million |
-0.553x | +69.24% |
| 2017-12-31 | ₩229.96 Million ≈ $155.84K |
₩-413.19 Million ≈ $-280.01K |
-1.797x | -2154.30% |
| 2016-12-31 | ₩2.28 Billion ≈ $1.55 Million |
₩-181.90 Million ≈ $-123.27K |
-0.080x | +94.83% |
| 2015-12-31 | ₩1.27 Billion ≈ $858.87K |
₩-1.95 Billion ≈ $-1.32 Million |
-1.541x | -- |
About Jeonjinbio Co. Ltd
Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 200… Read more